We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Roper (ROP) to Report Q3 Earnings: Is a Beat in the Cards?
Read MoreHide Full Article
Roper Technologies, Inc. (ROP - Free Report) is scheduled to report third-quarter 2020 results on Oct 27, before market open.
The company’s earnings beat expectations in the trailing four quarters, the average surprise being 5.44%. Notably, in the last reported quarter, earnings of $2.94 per share surpassed the Zacks Consensus Estimate of $2.67 by 10.11%.
In the past three months, the company’s shares have gained 3% compared with the industry’s growth of 10.7%.
Key Factors
Roper is likely to have benefited from strong momentum across the network software and medical products businesses in the third quarter. For instance, continued strength across the company’s DAT and ConstructConnect businesses are expected to have augmented its Network Software & Systems segment’s top-line performance. Notably, the Zacks Consensus Estimate for third-quarter revenues for the Network Software & Systems segment is pegged at $444 million, indicating a 5.2% increase from the previous quarter’s reported number.
For the Application Software segment, strength in the company’s laboratory software business, including Sunquest, Data Innovations and Clinisys, is likely to have aided revenues in the to-be-reported quarter. Also, solid booking for software products across Roper’s Deltek, Aderant and PowerPlan businesses amid the coronavirus outbreak is expected to have boosted the segment’s revenues in the quarter. The consensus mark for third-quarter revenues from the Application Software segment is pegged at $427 million, suggesting a 7.3% growth on a sequential basis.
Moreover, solid demand for medical products in its Verathon and IPA businesses along with improvement in the short-cycle industrial end markets is likely to have been a tailwind for the Measurement & Analytical Solutions segment. However, softness in the company’s other medical product businesses is likely to get reflected in the segment’s top-line performance. Notably, the consensus mark for Measurement & Analytical Solutions segment revenues stands at $369 million, implying a 1.4% sequential increase.
In addition, Roper’s unique niche market strategy, strong operational execution and cost-saving initiatives are likely to have helped it maintain a healthy margin performance amid the crisis.
However, persistent weakness in upstream oil and gas businesses is anticipated to have adversely impacted Roper’s Process Technologies segment in the third quarter. Notably, the consensus estimate for the Process Technologies segments’ revenues stands at $119 million, implying a 1.7% decrease on a sequential basis.
Earnings Whispers
Our proven model suggests an earnings beat for Roper this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The company has an Earnings ESP of +0.53% as the Most Accurate Estimate is pegged at $3.03, higher than the Zacks Consensus Estimate of $3.01.
Here are some other companies you may want to consider, as our model shows that these too have the right combination of elements to post an earnings beat this season:
IDEX Corporation (IEX - Free Report) has an Earnings ESP of +7.80% and a Zacks Rank #2.
ParkerHannifin Corporation (PH - Free Report) has an Earnings ESP of +5.44% and a Zacks Rank of 2, at present.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Roper (ROP) to Report Q3 Earnings: Is a Beat in the Cards?
Roper Technologies, Inc. (ROP - Free Report) is scheduled to report third-quarter 2020 results on Oct 27, before market open.
The company’s earnings beat expectations in the trailing four quarters, the average surprise being 5.44%. Notably, in the last reported quarter, earnings of $2.94 per share surpassed the Zacks Consensus Estimate of $2.67 by 10.11%.
In the past three months, the company’s shares have gained 3% compared with the industry’s growth of 10.7%.
Key Factors
Roper is likely to have benefited from strong momentum across the network software and medical products businesses in the third quarter. For instance, continued strength across the company’s DAT and ConstructConnect businesses are expected to have augmented its Network Software & Systems segment’s top-line performance. Notably, the Zacks Consensus Estimate for third-quarter revenues for the Network Software & Systems segment is pegged at $444 million, indicating a 5.2% increase from the previous quarter’s reported number.
For the Application Software segment, strength in the company’s laboratory software business, including Sunquest, Data Innovations and Clinisys, is likely to have aided revenues in the to-be-reported quarter. Also, solid booking for software products across Roper’s Deltek, Aderant and PowerPlan businesses amid the coronavirus outbreak is expected to have boosted the segment’s revenues in the quarter. The consensus mark for third-quarter revenues from the Application Software segment is pegged at $427 million, suggesting a 7.3% growth on a sequential basis.
Moreover, solid demand for medical products in its Verathon and IPA businesses along with improvement in the short-cycle industrial end markets is likely to have been a tailwind for the Measurement & Analytical Solutions segment. However, softness in the company’s other medical product businesses is likely to get reflected in the segment’s top-line performance. Notably, the consensus mark for Measurement & Analytical Solutions segment revenues stands at $369 million, implying a 1.4% sequential increase.
In addition, Roper’s unique niche market strategy, strong operational execution and cost-saving initiatives are likely to have helped it maintain a healthy margin performance amid the crisis.
However, persistent weakness in upstream oil and gas businesses is anticipated to have adversely impacted Roper’s Process Technologies segment in the third quarter. Notably, the consensus estimate for the Process Technologies segments’ revenues stands at $119 million, implying a 1.7% decrease on a sequential basis.
Earnings Whispers
Our proven model suggests an earnings beat for Roper this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The company has an Earnings ESP of +0.53% as the Most Accurate Estimate is pegged at $3.03, higher than the Zacks Consensus Estimate of $3.01.
Roper Technologies, Inc. Price and EPS Surprise
Roper Technologies, Inc. price-eps-surprise | Roper Technologies, Inc. Quote
Zacks Rank: Roper carries a Zacks Rank #2.
Other Key Picks
Here are some other companies you may want to consider, as our model shows that these too have the right combination of elements to post an earnings beat this season:
Flowserve Corporation (FLS - Free Report) has an Earnings ESP of +2.56% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
IDEX Corporation (IEX - Free Report) has an Earnings ESP of +7.80% and a Zacks Rank #2.
ParkerHannifin Corporation (PH - Free Report) has an Earnings ESP of +5.44% and a Zacks Rank of 2, at present.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>